BiliRecs is a clinical decision support tool based on the 2004 revised guidelines from the American Academy of Pediatrics to provide a framework for the prevention and management of hyperbilirubinemia (or Jaundice) in newborn infants of 35 or more weeks of gestation. The goal of this tool is to reduce the incidence of severe hyperbilirubinemia and bilirubin encephalopathy while minimizing the risks of unintended harm such as maternal anxiety, decreased breastfeeding, and unnecessary costs or treatment.
Peer-reviewed journal articles:
Development of a Web-based Decision Support Tool to Increase Use of Neonatal Hyperbilirubinemia Guidelines
Longhurst CA, Turner SW, Burgos AE
Journal of Quality and Patient Safety May 2009
Clinical Practice Guideline: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
AAP Subcommittee on Hyperbilirubinemia
Pediatrics July 2004
Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns
Bhutani VK, Johnson L, Sivieri EM
Pediatrics January 1999
Risk Factors for Neurotoxicity in Newborns With Severe Neonatal Hyperbilirubinemia
Gamaleldin R, Iskander I, Seoud I, Aboraya H, Aravkin A, Sampson PD, Wennberg RP
Pediatrics October 2011
The User acknowledges and agrees that this tool will be used only as a reference aid and that the information contained should not be used as a substitute for the exercise of professional diagnosis and treatment.
In view of the possibility of human error or changes in medical science, the User should confirm the information provided through independent sources. This tool is provided without warranties of any kind, expressed or implied, and Stanford University, Lucile Packard Children's Hospital/Stanford Children's Hospital, its staff, employees and faculty disclaim any liability, loss, damages, injury or liability whatsoever suffered as a result of the User's reliance on the information contained in this tool or its content.
By continuing to use this tool, the User indicated the acceptance of these terms.